Stay updated with breaking news from Cell Line Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The "Technology Developments in Viral Vector Manufacturing for Cell and Gene Therapies" report has been added to ResearchAndMarkets.com's...
Discover the latest tools and techniques to expand your research capacity with expert-led presentations on assay optimization, protein aggregation, cell line de
According to International Agency for Research on Cancer, the number of new cancer cases per year is expected to rise to 23.6 million by 2030 globally. In recent times, cell line development and its applications are considered as potential tools in oncology research. Cell lines are projected to be used for developme...
BERLIN, Germany, January 11, 2022 / B3C newswire / -- ProBioGen today announced that Innovent Biologics, Inc. (1801.HK) has signed a multi-product license for ProBioGen's GlymaxX technology.Under this license agreement, Innovent receives non-exclusive rights to use the afucosylation technology GlymaxX for multiple c...
Dublin, Jan. 07, 2022 (GLOBE NEWSWIRE) -- The "Technology Developments in Viral Vector Manufacturing for Cell and Gene Therapies" report has been added...